Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to determine the progression-free survival (PFS) of patients with metastatic malignant melanoma who have not received prior chemotherapy for metastatic disease when treated with IMC-1121B alone or in combination with dacarbazine.
Inclusion criteria
- Metastatic Malignant Melanoma